Showing 1 - 16 results of 16 for search 'Carin A Uyl-de Groot', query time: 0.03s
Refine Results
-
1
Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands by Nicolas S. H. Xander, Nicolas S. H. Xander, W. Edward Fiets, Carin A. Uyl-de Groot, Carin A. Uyl-de Groot, Carin A. Uyl-de Groot
Published 2023-06-01
Article -
2
-
3
-
4
-
5
-
6
Assessing the impact of caregiving on informal caregivers of adults with a mental disorder in OECD countries: A systematic literature review of concepts and their respective questi... by Leonarda G M Bremmers, Isabelle N Fabbricotti, Eleonora S Gräler, Carin A Uyl-de Groot, Leona Hakkaart-van Roijen
Published 2022-01-01
Article -
7
Fair Pricing of Innovative Medicines: An EHA Position Paper by Anton Hagenbeek, John Gribben, Ulrich Jäger, Peter Kapitein, Giampaolo Merlini, Maria Piggin, Carin A. Uyl-de Groot, Robin Doeswijk
Published 2020-10-01
Article -
8
-
9
Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach by Marloes E. Clarijs, Jacob Thurell, Friedrich Kühn, Carin A. Uyl-de Groot, Elham Hedayati, Maria M. Karsten, Agnes Jager, Linetta B. Koppert
Published 2021-05-01
Article -
10
-
11
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future by Renaud Heine, Frederick W. Thielen, Marc Koopmanschap, Marie José Kersten, Hermann Einsele, Ulrich Jaeger, Pieter Sonneveld, Jorge Sierra, Carin Smand, Carin A. Uyl-de Groot
Published 2021-02-01
Article -
12
Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study by Céline van de Braak, François E. J. A. Willemssen, Rob A. de Man, Aad van der Lugt, Carin A. Uyl-de Groot, Daniel Bos, Roy S. Dwarkasing
Published 2024-03-01
Article -
13
Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands by Anne Kleijburg, C. Louwrens Braal, Justin D. Westenberg, Agnes Jager, Stijn L.W. Koolen, Ron H.J. Mathijssen, Carin A. Uyl-de Groot, Pim Wetzelaer, Hannah Penton
Published 2023-02-01
Article -
14
-
15
P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE PRE-CAR-T ERA: A DUTCH POPULATION-BASED STUDY by Elise R.A. Pennings, Müjde Durmaz, Otto Visser, Eduardus F.M. Posthuma, Djamila E. Issa, Martine E.D. Chamuleau, Anne M. Spanjaart, Tom van Meerten, Pim G.N.J. Mutsaers, Margot Jak, Suzanne van Dorp, Joost S.P. Vermaat, Marjolein W.M. van der Poel, Maria T. Kuipers, Frederick W. Thielen, Carin A. Uyl-de Groot, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed
Published 2023-08-01
Article -
16
Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs by Brenda Leeneman, Carin A. Uyl-de Groot, Maureen J. B. Aarts, Alexander C. J. van Akkooi, Franchette W. P. J. van den Berkmortel, Alfons J. M. van den Eertwegh, Jan Willem B. de Groot, Karin H. Herbschleb, Jacobus J. M. van der Hoeven, Geke A. P. Hospers, Ellen Kapiteijn, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Albert J. ten Tije, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, John B. A. G. Haanen, Margreet G. Franken
Published 2020-04-01
Article